AIM
FLGT icon

Alambic Investment Management’s Fulgent Genetics FLGT Stock Holding History

Alambic Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-27,166
Closed -$435K – 106
2020
Q2 		$435K Sell
27,166
-7,601
-22% -$116K 1.09% 23
2020
Q1 		$374K Sell
34,767
-35,910
-51% -$500K 0.9% 34
2019
Q4 		$912K Sell
70,677
-13,401
-16% -$159K 0.76% 27
2019
Q3 		$874K Buy
+84,078
New +$797K 0.66% 45

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RJT
Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alambic Investment Management's FLGT Position: Q3 2020 in Review

Alambic Investment Management sold out of Fulgent Genetics (FLGT) in Q3 2020, closing a stake of 27,166 shares — an estimated $435K sold.

Alambic Investment Management first reported a position in FLGT in Q3 2019 and held it in 4 quarters. The position peaked at $912K in Q4 2019. 126 funds tracked by Wall St. Rank hold FLGT as of Q3 2020.

  • Alambic Investment Management reported no remaining Fulgent Genetics position as of Q3 2020 after selling out during the quarter.
  • Alambic Investment Management sold 27,166 Fulgent Genetics shares in Q3 2020, an estimated $435K.
  • Alambic Investment Management first reported a position in Fulgent Genetics in Q3 2019 and held it in 4 quarters.
  • Alambic Investment Management's Fulgent Genetics position peaked at $912K in Q4 2019.
  • 126 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2020.

Based on Alambic Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.